Free Trial

BioNexus Gene Lab Q2 2024 Earnings Report

$0.23 -0.05 (-18.40%)
As of 04/4/2025 03:59 PM Eastern

BioNexus Gene Lab EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioNexus Gene Lab Revenue Results

Actual Revenue
$1.98 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioNexus Gene Lab Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

BioNexus Gene Lab Earnings Headlines

BioNexus Gene Lab Corp trading halted, news pending
Bionexus Gene Lab enters partnership with ML Tech
Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
See More BioNexus Gene Lab Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioNexus Gene Lab? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNexus Gene Lab and other key companies, straight to your email.

About BioNexus Gene Lab

BioNexus Gene Lab (NASDAQ:BGLC), through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

View BioNexus Gene Lab Profile

More Earnings Resources from MarketBeat